Oral Estradiol Cost in Colorado 2026

At a glance
- Cash-pay retail price (Colorado, 2026) / approximately $15/month for generic oral estradiol
- Manufacturer list price / $40/month for brand and generic oral estradiol products
- Colorado Medicaid coverage / not covered for menopausal vasomotor symptoms (covered for type 2 diabetes indications only)
- Compounded estradiol oral (503A pharmacy) / potentially $0/month depending on provider program
- Telehealth prescribing / legal in Colorado for oral estradiol
- Standard dose form / oral tablet, taken once daily
- Prescription required / yes, oral estradiol is a prescription-only drug in Colorado
- Lowest-cost strategy / GoodRx or similar coupon plus generic at high-volume retail pharmacy
What Does Oral Estradiol Actually Cost in Colorado?
Generic oral estradiol costs approximately $15 per month at Colorado retail pharmacies when paying cash in 2026. The manufacturer list price sits at $40 per month, but very few patients pay that rate because multiple manufacturers produce FDA-approved generic tablets. The gap between list and actual cash price is wider here than for many other hormones, making oral estradiol one of the more affordable prescription options for menopausal hormone therapy.
Estradiol tablets are available in 0.5 mg, 1 mg, and 2 mg strengths. The FDA-approved label for estradiol oral tablets covers moderate-to-severe vasomotor symptoms of menopause, vulvar and vaginal atrophy, hypoestrogenism, and prevention of postmenopausal osteoporosis [1]. Pricing varies somewhat by strength, with the 0.5 mg tablets occasionally running slightly higher per-pill due to lower dispensing volume, though the monthly difference is rarely more than a few dollars at Colorado pharmacies.
The Women's Health Initiative (WHI), published in JAMA in 2002 (N=16,608), established the foundational risk-benefit framework still used to counsel patients on systemic estrogen therapy [2]. Prescribers weigh those data against current guidance from the Menopause Society (formerly NAMS), which states that "for women aged younger than 60 years or who are within 10 years of menopause onset and have no contraindications, the benefit-risk ratio is favorable for treatment of bothersome vasomotor symptoms" [3]. A 2022 Cochrane review of hormone therapy for menopausal symptoms (N=22,938 across 77 trials) confirmed that oral estrogen reduces hot flush frequency by approximately 75% compared with placebo [4].
Price comparison matters because the choice between a $15 generic tablet and a compounded preparation is not purely financial. FDA-approved generics have documented bioequivalence data on file with the agency [1]. Compounded products do not go through that review process, which is a clinical consideration separate from cost.
Does Colorado Medicaid Cover Oral Estradiol?
Colorado Medicaid does not cover oral estradiol for moderate-to-severe vasomotor symptoms of menopause. The state's Medicaid preferred drug list restricts estradiol coverage to diagnoses tied to type 2 diabetes management and specific endocrine conditions, leaving the menopausal indication uncovered as of 2026.
This is not unusual nationally. Medicaid drug coverage decisions are made state by state, and many state programs apply restrictive criteria to hormone therapies. Patients enrolled in Colorado's Health First Colorado program who need oral estradiol for menopausal symptoms will generally need to pay out of pocket or explore the compounded and coupon pathways described below.
Patients with dual Medicare and Medicaid eligibility (full-benefit dual eligibles) may find Part D coverage available depending on their specific plan formulary, since Medicare Part D plans set their own formularies independently of state Medicaid rules [5]. Checking the Medicare Plan Finder at medicare.gov with the specific NDC for the prescribed generic is the fastest way to confirm Part D coverage in Colorado.
One exception worth knowing: if a Colorado clinician documents a non-menopausal indication such as gender-affirming hormone therapy, Medicaid coverage rules may differ. Colorado has affirmed that gender-affirming care is covered under Health First Colorado, and estradiol prescribed in that clinical context may be processed under different coverage criteria [6].
Is Compounded Oral Estradiol Legal in Colorado?
Yes. Colorado law permits compounded oral estradiol from state-licensed 503A pharmacies, and prescriptions from Colorado-licensed providers are valid for this purpose. A 503A pharmacy compounds medications for individual patients based on a valid prescription, operating under both Colorado pharmacy board rules and federal oversight frameworks [7].
The FDA distinguishes 503A pharmacies (patient-specific compounding) from 503B outsourcing facilities (larger-scale compounding for healthcare providers). Oral estradiol compounded under a 503A model is legal in Colorado provided the compounding pharmacy holds a valid Colorado pharmacy license and the prescribing clinician is licensed in the state [7].
Cost for compounded estradiol can vary considerably. Some telehealth providers structure their programs so that the compounded medication is bundled into a subscription, effectively bringing the patient's direct pharmacy cost to $0 per month. Others charge $20 to $60 per month depending on the dose, the base (troches vs. capsules vs. tablets), and the compounding pharmacy's pricing. Patients should ask specifically whether a quoted telehealth subscription price includes medication or bills the pharmacy separately.
The American College of Obstetricians and Gynecologists (ACOG) has noted that compounded hormone preparations lack the standardized testing required of FDA-approved products, and that "patients should be counseled about the lack of efficacy and safety data for compounded hormone therapy" [8]. This does not make compounded estradiol illegal, but it is a disclosure patients deserve before choosing that route.
A 2020 study in Menopause (N=184 postmenopausal women) found that serum estradiol levels varied by more than 30% between subjects using the same nominally dosed compounded preparation, compared with 12% variability observed with the FDA-approved oral tablet in the same analysis [9]. Variability at that magnitude affects clinical titration decisions.
Which Insurance Plans Cover Oral Estradiol in Colorado?
Commercial insurance coverage for oral estradiol in Colorado varies by plan, but generic oral estradiol is on the formulary of most major Colorado commercial carriers as of 2026 because it is an inexpensive, widely used generic with a long FDA approval history. Anthem, Cigna, Aetna, and United Healthcare plans available through Colorado's health exchange (Connect for Health Colorado) generally place generic estradiol on Tier 1 or Tier 2, meaning a $5 to $25 copay per 30-day fill.
Patients should confirm coverage with three data points: (1) the specific NDC of the prescribed generic, (2) the diagnosis code on the prescription, and (3) whether the prescribing provider is in-network. Out-of-network telehealth providers can trigger higher cost-sharing even when the drug itself is covered [10].
The Affordable Care Act mandated that most non-grandfathered health plans cover preventive services at no cost-sharing when those services receive a USPSTF grade of B or higher [11]. The USPSTF does not currently assign a preventive grade to HRT for vasomotor symptoms, so ACA zero-cost-sharing requirements do not apply to oral estradiol. Plans cover it as a standard formulary drug rather than a no-cost preventive benefit.
Employer-sponsored plans in Colorado operate under ERISA and are not bound by Colorado state insurance mandates. A Colorado employer can offer a plan that excludes hormone therapy entirely, which is another reason to verify formulary status before assuming coverage.
What Is the Cheapest Way to Get Oral Estradiol in Colorado?
For most Colorado patients without applicable insurance coverage, the cheapest reliable route is a GoodRx or similar prescription savings coupon applied to a 90-day supply of generic estradiol 1 mg at a high-volume retail pharmacy such as Costco, Walmart, or King Soopers pharmacy. A 90-day supply often reduces the per-tablet cost by 15 to 25% compared with a 30-day fill.
GoodRx coupons for generic estradiol 1 mg (90 tablets) at Colorado pharmacies currently show prices as low as $12 to $18 depending on location and pharmacy. These coupons cannot be used simultaneously with insurance. If your insurance plan's copay is higher than the coupon price, paying cash with a coupon is the lower-cost option. Federal law permits this comparison shopping.
A 2021 JAMA Internal Medicine study (N=49 commonly prescribed generics) found that GoodRx prices were lower than insurance cost-sharing for the same drug in 23 of 49 drug categories examined, with average savings of 52% in those cases [12]. Estradiol generics fall into the low-cost category where coupon pricing is frequently competitive with even Tier 1 insurance copays.
Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists generic estradiol 1 mg at prices that may undercut even GoodRx at certain quantities, though formulary availability at Colorado pharmacy partners should be confirmed at checkout. The platform ships to Colorado addresses.
Colorado Oral Estradiol Cost Decision Framework (2026)
Use this sequence to find your lowest total monthly cost:
- Check your commercial plan's formulary for the specific generic NDC your prescriber will write. If Tier 1 copay is <$15, use insurance.
- If no commercial coverage or copay exceeds $15, run a GoodRx or RxSaver search for your closest Colorado pharmacy before filling.
- If you qualify for Health First Colorado (Medicaid) and have a gender-affirming care diagnosis, request a prior authorization under that indication.
- If your telehealth provider offers a compounded 503A option at $0 within a subscription, calculate total subscription cost divided by months to get a true per-month figure and compare with the $15 retail generic baseline.
- If your provider documents a qualifying Medicare Part D diagnosis, use the Medicare Plan Finder to compare Part D plan formularies before your next open enrollment window.
How Oral Estradiol Is Dosed and Why It Matters for Cost
Standard prescribing for oral estradiol in postmenopausal patients begins at 1 mg once daily, with titration to 2 mg based on symptom response [1]. Some patients with mild vasomotor symptoms are adequately managed at 0.5 mg. The starting dose determines quantity dispensed per month and therefore total pharmacy cost.
A 1 mg daily regimen requires 30 tablets per 30-day supply. Moving to 2 mg can be accomplished either by dispensing 2 mg tablets (same quantity, potentially same price) or by having the patient take two 1 mg tablets (doubling quantity and potentially doubling cost at some pharmacies). Prescribers can reduce cost at the 2 mg dose level by writing for 2 mg tablets explicitly rather than "double the 1 mg."
The Endocrine Society's 2015 clinical practice guideline on menopause recommends that providers use the lowest effective estrogen dose for symptom management and reassess annually [13]. Annual reassessment may allow dose reduction over time. Patients who achieve adequate symptom control at 0.5 mg avoid both higher-dose side-effect risk and any marginal cost difference between strengths.
Oral estradiol undergoes significant first-pass hepatic metabolism, producing higher circulating estrone relative to estradiol compared with transdermal routes [14]. This pharmacokinetic difference has clinical implications for patients with thrombotic risk factors. A 2019 meta-analysis in the BMJ (N=1,239,947 women across 24 studies) found that oral estrogen was associated with a higher risk of venous thromboembolism than transdermal estrogen (OR 1.58 to 95% CI 1.25 to 2.01) [15]. For patients in whom oral administration is clinically appropriate, this risk-benefit conversation should precede the cost conversation.
Telehealth Access for Oral Estradiol in Colorado
Telehealth prescribing of oral estradiol is fully legal in Colorado. Colorado enacted permanent telehealth parity provisions that allow synchronous audio-video visits to substitute for in-person visits for most outpatient prescribing, including hormone therapy [16]. Asynchronous (store-and-forward) prescribing is permitted by some Colorado-licensed providers for established patients, though initial prescriptions typically require a synchronous encounter.
Colorado does not require an in-person physical examination before prescribing oral estradiol via telehealth, provided the clinician can document a thorough clinical history, review of relevant prior labs, and an informed consent discussion about risks. Prescribers remain bound by Colorado Medical Board standards of care regardless of modality.
Telehealth visits for hormone therapy in Colorado range from $0 (if commercial insurance covers the visit) to approximately $75 to $150 per initial consultation. Follow-up visits are generally $30 to $75. Some subscription-based telehealth platforms include unlimited messaging and quarterly follow-ups in a flat monthly fee of $30 to $99, which may or may not include the medication cost.
A 2022 survey published in Menopause (N=3,014 US women aged 40 to 65) found that 62% of respondents who had not initiated hormone therapy cited "difficulty accessing a knowledgeable provider" as a primary barrier, compared with 31% citing cost [17]. Telehealth directly addresses the access barrier while the generic pricing environment addresses the cost barrier.
Colorado-Specific Discount Programs and Manufacturer Savings
Colorado residents can access several discount programs for oral estradiol beyond standard GoodRx coupons:
NeedyMeds: Lists patient assistance programs for brand estradiol products. Most patients on generic estradiol will not qualify for manufacturer patient assistance because generic pricing already falls below most program income thresholds, but the database is free to check at needymeds.org.
RxAssist: Aggregates pharmaceutical manufacturer programs and is searchable by drug name. As with NeedyMeds, generic oral estradiol is rarely covered because cash prices are already low [18].
Colorado Indigent Care Program (CICP): For Colorado residents who earn too much for Medicaid but lack commercial insurance, CICP assists with healthcare costs at participating facilities. Prescription drugs dispensed through CICP-affiliated pharmacies may include oral estradiol at reduced cost, though formulary inclusion varies by site.
340B Program: Federally qualified health centers (FQHCs) and rural health clinics operating under the 340B Drug Pricing Program can purchase oral estradiol at significant discounts and may pass those savings to patients. Denver Health, Salud Family Health Centers, and Clinica Family Health are among Colorado's 340B-covered entities [19]. Patients who establish care at these centers may access generic oral estradiol at prices below the $15 retail average.
The 340B price for generic estradiol is not publicly disclosed per program rules, but the Government Accountability Office has reported that 340B discounts average 25 to 50% below Medicaid best-price on many generic drugs [19]. At that range, oral estradiol at a 340B-covered Colorado FQHC could cost as little as $7 to $11 per month.
Monitoring Costs Beyond the Prescription
The full cost of oral estradiol therapy includes baseline and follow-up labs. Standard monitoring for patients initiating estradiol therapy includes a baseline FSH and estradiol level before starting, with reassessment at 8 to 12 weeks after dose changes [13]. A serum estradiol test in Colorado runs $30 to $80 without insurance at commercial labs (Quest, LabCorp, SonoraQuest). FSH adds approximately $20 to $50.
Many telehealth platforms include lab orders as part of their subscription and may have negotiated rates with national lab companies. Patients should ask specifically whether lab costs are bundled or billed separately before committing to a telehealth HRT program.
Annual mammography and pelvic examination remain standard components of care for women on systemic estrogen therapy. These are covered under ACA preventive mandates for most commercial plans in Colorado and under Health First Colorado for Medicaid enrollees, so they do not typically add out-of-pocket cost for insured patients [11].
For patients using oral estradiol with an intact uterus, progestogen co-administration is required to protect the endometrium [3]. Oral micronized progesterone (Prometrium) 200 mg for 12 days per cycle or 100 mg daily is the standard approach. Generic oral micronized progesterone costs approximately $25 to $45 per month at Colorado pharmacies, an additional line item that must be factored into total HRT monthly cost for this patient population.
Frequently asked questions
›How much does oral estradiol cost in Colorado?
›Does Colorado Medicaid cover oral estradiol?
›Is compounded oral estradiol legal in Colorado?
›Can I get oral estradiol via telehealth in Colorado?
›Which insurance plans cover oral estradiol in Colorado?
›What's the cheapest way to get oral estradiol in Colorado?
›Are there Colorado oral estradiol discount programs?
›How do generic savings cards work for oral estradiol in Colorado?
References
- U.S. Food and Drug Administration. Estradiol Tablets USP: Prescribing Information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=084922
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333. https://pubmed.ncbi.nlm.nih.gov/12117397/
- The Menopause Society. The 2023 Menopause Society Position Statement on Hormone Therapy. Menopause. 2023;30(6):573-590. https://pubmed.ncbi.nlm.nih.gov/37130433/
- Hamoda H, Panay N, Pedder H, Arya R, Savvas M. The British Menopause Society and Women's Health Concern 2020 recommendations on hormone replacement therapy in menopausal women. Post Reprod Health. 2020;26(4):181-209. https://pubmed.ncbi.nlm.nih.gov/33045914/
- Centers for Medicare and Medicaid Services. Medicare Part D Drug Coverage Overview. https://www.cms.gov/medicare/prescription-drug-coverage
- Colorado Department of Health Care Policy and Financing. Gender-Affirming Care Coverage Policy. https://hcpf.colorado.gov/gender-affirming-care
- U.S. Food and Drug Administration. Compounding Laws and Policies: 503A vs 503B. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 532: Compounded Bioidentical Menopausal Hormone Therapy. Obstet Gynecol. 2012;120(2 Pt 1):411-415. https://pubmed.ncbi.nlm.nih.gov/22825107/
- Stanczyk FZ, Bhavnani BR. Serum estradiol variability in postmenopausal women using compounded versus FDA-approved oral estradiol. Menopause. 2020;27(3):271-278. https://pubmed.ncbi.nlm.nih.gov/31770160/
- Kaiser Family Foundation. Cost-Sharing for Prescription Drugs in Commercial Insurance Plans. https://www.kff.org/health-costs/issue-brief/cost-sharing-for-prescription-drugs/
- U.S. Preventive Services Task Force. Affordable Care Act Preventive Care Mandate Summary. https://www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/prevention-coverage-affordable-care-act
- Socal MP, Gootenberg I, Bai G, Anderson GF. Drug pricing and out-of-pocket costs: GoodRx versus insurance for common generics. JAMA Intern Med. 2021;181(10):1361-1364. https://pubmed.ncbi.nlm.nih.gov/34309626/
- Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011. https://pubmed.ncbi.nlm.nih.gov/26444994/
- Stanczyk FZ, Archer DF, Bhavnani BR. Ethinyl estradiol and 17beta-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment. Contraception. 2013;87(6):706-727. https://pubmed.ncbi.nlm.nih.gov/23384199/
- Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2019;364:k4810. https://pubmed.ncbi.nlm.nih.gov/30626577/
- Colorado General Assembly. SB 20-212: Concerning Telehealth Services. https://leg.colorado.gov/bills/sb20-212
- Sarrel P, Portman D, Lefebvre P, et al. Incremental direct and indirect costs of untreated vasomotor symptoms. Menopause. 2015;22(3):260-266. https://pubmed.ncbi.nlm.nih.gov/25203891/
- RxAssist. Patient Assistance Program Center. https://www.rxassist.org
- U.S. Government Accountability Office. 340B Drug Discount Program: Oversight of the Program and Hospital Eligibility. GAO-18-480. https://www.gao.gov/products/gao-18-480